BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27754579)

  • 1. A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor.
    Yamada Y; Takayama KI; Fujimura T; Ashikari D; Obinata D; Takahashi S; Ikeda K; Kakutani S; Urano T; Fukuhara H; Homma Y; Inoue S
    Cancer Sci; 2017 Jan; 108(1):32-41. PubMed ID: 27754579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
    Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma.
    Yamada Y; Kimura N; Takayama KI; Sato Y; Suzuki T; Azuma K; Fujimura T; Ikeda K; Kume H; Inoue S
    Cancer Sci; 2020 Mar; 111(3):881-890. PubMed ID: 31883420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of TRIM44 Inhibits the Proliferation and Invasion in Prostate Cancer Cells.
    Tan Y; Yao H; Hu J; Liu L
    Oncol Res; 2017 Sep; 25(8):1253-1259. PubMed ID: 28160462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.
    Xiong D; Jin C; Ye X; Qiu B; Jianjun X; Zhu S; Xiang L; Wu H; Yongbing W
    Cancer Sci; 2018 Oct; 109(10):3080-3092. PubMed ID: 30098109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4.
    Wei CY; Wang L; Zhu MX; Deng XY; Wang DH; Zhang SM; Ying JH; Yuan X; Wang Q; Xuan TF; He AQ; Qi FZ; Gu JY
    J Exp Clin Cancer Res; 2019 Mar; 38(1):137. PubMed ID: 30922374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachyury oncogene is a prognostic factor in high-risk testicular germ cell tumors.
    Pinto F; Cárcano FM; da Silva ECA; Vidal DO; Scapulatempo-Neto C; Lopes LF; Reis RM
    Andrology; 2018 Jul; 6(4):597-604. PubMed ID: 29749711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
    Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
    Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma.
    Kashimoto K; Komatsu S; Ichikawa D; Arita T; Konishi H; Nagata H; Takeshita H; Nishimura Y; Hirajima S; Kawaguchi T; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Cancer Sci; 2012 Nov; 103(11):2021-6. PubMed ID: 22862969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome.
    Li P; Yin H; Meng F; Liu S; Liu H; Ma R
    Pathol Res Pract; 2018 May; 214(5):727-731. PubMed ID: 29526558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer.
    Yu Y; Li S; Sun J; Wang Y; Xie L; Guo Y; Li J; Han F
    Genes Genomics; 2024 Jun; 46(6):689-699. PubMed ID: 38691326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of SPRY4 and SPRY4-IT1 inhibits cell growth and phosphorylation of Akt in human testicular germ cell tumours.
    Das MK; Furu K; Evensen HF; Haugen ØP; Haugen TB
    Sci Rep; 2018 Feb; 8(1):2462. PubMed ID: 29410498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of splicing variants of the inhibitor of apoptosis livin in testicular germ cell tumors.
    Kempkensteffen C; Hinz S; Krause H; Jager T; Köllermann J; Weikert S; Christoph F; Schostak M; Miller K; Schrader M
    Tumour Biol; 2008; 29(2):76-82. PubMed ID: 18515985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.
    Zhu X; Wu Y; Miao X; Li C; Yin H; Yang S; Lu X; Liu Y; Chen Y; Shen R; Chen X; He S
    Tumour Biol; 2016 Nov; 37(11):14615-14628. PubMed ID: 27619678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between tripartite motif-containing protein 44 protein expression and the prognosis of postoperative patients exhibiting skin squamous cell carcinoma.
    Wu J; Guo NZ; Cui LL; Wang W; Xiong CQ; Zhang XY
    Medicine (Baltimore); 2018 Nov; 97(44):e13021. PubMed ID: 30383661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of spermatogenesis-associated protein 6 in testicular germ cell tumors.
    Huo S; Du W; Shi P; Si Y; Zhao S
    Int J Clin Exp Pathol; 2015; 8(8):9119-25. PubMed ID: 26464655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.
    Xing Y; Meng Q; Chen X; Zhao Y; Liu W; Hu J; Xue F; Wang X; Cai L
    Oncotarget; 2016 May; 7(21):30479-91. PubMed ID: 27058415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of TRIM44 and its correlation with TLR4 in laryngeal squamous cell carcinoma.
    Bai J; Liu X; Zhang S; Dang S; Zhang Y; Zhang G
    Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):56-61. PubMed ID: 36227676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.
    Kawaguchi T; Komatsu S; Ichikawa D; Hirajima S; Nishimura Y; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Tumour Biol; 2017 Jun; 39(6):1010428317700409. PubMed ID: 28618928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tripartite Motif-Containing 44 is Involved in the Tumorigenesis of Laryngeal Squamous Cell Carcinoma, and its Expression is Downregulated by Nuciferine.
    Li QH; Sui LP; Zhao YH; Chen BG; Li J; Ma ZH; Hu ZH; Tang YL; Guo YX
    Tohoku J Exp Med; 2021 May; 254(1):17-23. PubMed ID: 34011804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.